GS EFFEX

Serial Number 79384105
Registration 7452422
700

Registration Progress

Application Filed
Sep 21, 2023
Under Examination
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered
Jul 23, 2024

Trademark Image

GS EFFEX

Basic Information

Serial Number
79384105
Registration Number
7452422
Filing Date
September 21, 2023
Registration Date
July 23, 2024
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 23, 2024
Registration
Registered
Classes
001 005 040 042

Rights Holder

Lonza Ltd.

25
Address
Lonzastrasse
CH-3930 Visp
CH

Ownership History

Lonza Ltd.

Original Applicant
25
CH

Lonza Ltd.

Owner at Publication
25
CH

Lonza Ltd.

Original Registrant
25
CH

Legal Representation

Attorney
LAWRENCE J CRAIN

USPTO Deadlines

Next Deadline
1828 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-23)
Due Date
July 23, 2030
Grace Period Ends
January 23, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
May 17, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Apr 29, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 29, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Feb 8, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 16, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 16, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 24, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 8, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 30, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 30, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 30, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 28, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 28, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 20, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 20, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 29, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 28, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 8, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 30, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Biological preparations for scientific research, pharmaceutical research, clinical research and for industrial purposes namely, genetically modified cells and vectors for production of human, animal and synthetic proteins
Class 005
Biological preparations, namely, genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins, for medical and clinical use in human and animal therapies
Class 040
Custom manufacturing according to third-party orders and specifications of genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial use in scientific research and in pharmaceutical research, as well as for clinical and commercial use in human and animal therapies
Class 042
Medical and scientific research in the field of biotechnology; technical consultancy and project planning in the field of biological research relating to proteins; scientific research and development in the field of protein research for others

Classification

International Classes
001 005 040 042